jueves, 7 de marzo de 2019

Clinicians embracing esketamine with 'enthusiastic caution' - STAT

Clinicians embracing esketamine with 'enthusiastic caution' - STAT

Daily Recap

Clinicians embracing new depression drug esketamine with ‘enthusiastic caution’

By MEGAN THIELKING


STAT
Here’s a look at key questions as the depression drug, which will be sold under the brandname Spravato, heads to the market.

No hay comentarios: